Health Care

The U.S. House of Representatives today approved Congressman Earl L. "Buddy" Carter's (R-Ga.) legislation to help lower prescription drug costs and increase transparency in the drug supply chain.  Currently, Congress’ independent advisory commissions, the Medicare Payment Advisory Commission (MedPAC) and the Medicaid and CHIP Payment and Access Commission (MACPAC), do not have… Read more »

Congressman Earl L. "Buddy" Carter (R-Ga.) today applauded the Trump administration's announcement of a nearly $20 million State Opioid Response (SOR) grant for the state of Georgia. This grant from the Substance Abuse and Mental Health Services Administration will provide funding to the state government to support opioid abuse prevention, treatment and recovery… Read more »

This week, Representatives Roger Marshall, MD (KS-01), Peter Welch (VT-At Large), Earl L. “Buddy” Carter (GA-01), and Vicente Gonzalez (TX-15), introduced H.R. 3223, the Pharmacy Benefit Manger Accountability Study Act of 2019.  This bipartisan legislation directs the Government Accountability Office (GAO) to conduct a study on the role pharmaceutical benefit managers (PBMs) play in… Read more »

Congressman Earl L. "Buddy" Carter (R-Ga.) slammed House Democrats today for bringing legislation titled the Protecting Americans with Pre-existing Conditions Act to a vote when the legislation does not address pre-existing conditions. Instead, the legislation would hinder the ability of states to lower premiums for Americans across the country.  On the floor,… Read more »

Congressman Earl L. "Buddy" Carter's (R-Ga.) bipartisan legislation to increase transparency in the drug pricing system was approved by the House Energy and Commerce Committee's Health Subcommittee today.  Currently, Congress’ independent advisory commissions, the Medicare Payment Advisory Commission (MedPAC) and the Medicaid and CHIP Payment and Access Commission (MACPAC), do not… Read more »

Today Representative Earl L. “Buddy” Carter (R-Ga.) along with Representatives Tom O’Halleran (D-Az.), Tom Rice (R-Sc.) and Jimmy Panetta (D-Ca.) introduced bipartisan legislation to increase transparency in the drug pricing system. Currently, Congress’ independent advisory commissions, the Medicare Payment Advisory Commission (MedPAC) and the Medicaid and CHIP Payment and Access… Read more »

Congressman Earl L. "Buddy" Carter (R-Ga.) and Congressman Kurt Schrader (D-Or.) today introduced legislation aimed at keeping drug prices down by increasing competition in the generic drug market.  Current law awards 180 days of exclusivity on the market to a drug manufacturer when they are the first to file a generic drug application with the FDA for a drug for which there… Read more »

President Donald Trump today signed into law a bipartisan, bicameral package designed to combat the opioid epidemic. Included in the package are three bills introduced by Congressman Earl L. "Buddy" Carter (R-Ga.) as part of his ongoing efforts to end the epidemic. "I am excited and proud that this package was signed into law today," said Carter. "While working with members… Read more »

Congressman Earl L. "Buddy" Carter (R-Ga.) joined President Donald Trump today at the White House as he signed legislation to prohibit "gag clause" provisions into law.  Today, President Trump signed two Senate companion bills to Carter's Know the Cost Act. These bills prohibit "gag clause" provisions in Medicare as well as in group or individual health… Read more »

Today the U.S. House of Representatives approved a bipartisan, bicameral opioid package designed to combat the opioid epidemic. Included in the package are three bills introduced by Congressman Earl L. "Buddy" Carter (R-Ga.) as part of his ongoing efforts to end the epidemic. "We are losing 115 Americans every day to the opioid crisis," said Carter. "As a pharmacist, I viewed… Read more »